Veritas Patented NADH Pellets utilize advanced microencapsulation technology to overcome the inherent instability of NADH (reduced nicotinamide adenine dinucleotide). Our proprietary multi-core soluble wall matrix protects the active ingredient from oxygen, moisture, light, and gastric acid degradation, delivering targeted intestinal release with 24-hour sustained-release profile.
NADH (Reduced Nicotinamide Adenine Dinucleotide, CAS: 606-68-8) is the reduced form of NAD+ and one of the most important coenzymes in cellular metabolism. It plays a critical role in mitochondrial ATP production, DNA repair, and aging regulation. However, NADH is extremely sensitive to temperature, light, oxygen, moisture, and pH — unprotected powder degrades by 50% within 6-12 months and requires -20°C storage.
Veritas Patented NADH Pellets solve this industry challenge through our proprietary Veritas® microencapsulation technology. Using a "multi-core + soluble wall matrix" structure, the pellets completely isolate NADH from environmental factors while enabling acid-resistant, intestinal-targeted delivery with 24-hour sustained release.
Every batch is manufactured under strict GMP conditions and tested against international quality standards. Each shipment includes a full Certificate of Analysis (COA) covering NADH purity, particle size distribution, dissolution profile, microbial limits, and heavy metals. Our facility is ISO 9001, ISO 22000, FDA-registered, and Halal certified.
How our patented microencapsulation technology outperforms unprotected NADH powder.
| Specification | Standard NADH | NADH Pellets |
|---|---|---|
| Shelf Life (Room Temp.) | 6-12 months | 36 months (6x longer) |
| Storage Requirement | -20°C sealed | Room temp. protected |
| Gastric Acid Resistance | Mostly destroyed | Intestinal-targeted release |
| Release Duration | Short, rapid | 24 hours sustained |
| Bioavailability (NAD+ ↑ in 2 weeks) | 10.9% | 44.8% (4.1x higher) |
| Formulation Compatibility | Limited (degrades) | Fully compatible |
| Patent Protection | — | US 11744804B2 |
The multi-core soluble wall matrix technology that protects NADH and delivers it where it matters.
Nano-scale NADH active cores are encapsulated within a soluble polymer wall matrix, forming 250-350μm micro-pellets.
The wall material completely blocks oxygen, moisture, and light, maintaining NADH stability for 36 months at room temperature.
Pellets survive gastric acid intact and reach the intestine, where the soluble wall releases active NADH for absorption.
The multi-core structure gradually releases NADH over 24 hours, extending absorption window by 5-8x vs. immediate release.
A four-layer engineered micro-pellet designed for maximum stability and targeted delivery.
Acid-resistant outer shell
Protects the pellet from gastric acid degradation. Dissolves only at pH 6.0+ in the intestine, ensuring NADH survives stomach transit intact.
24-hour controlled release
Semi-permeable polymer film that controls the release rate of NADH. Regulates diffusion to maintain steady blood levels over 24 hours.
Multi-core encapsulation
Patented "multi-core + soluble wall" structure. Completely isolates NADH from oxygen, moisture, and light. Dissolves fully in the intestine with zero residue.
≥98% purity reduced coenzyme I
Nano-scale NADH crystals encapsulated in multi-core format. The reduced form of NAD+, directly participates in mitochondrial ATP synthesis.
How the four-layer pellet travels through the body and delivers NADH where it matters.
Pellet swallowed with water. Enteric coating seals NADH inside, protected from the external environment.
Gastric acid (pH 1.5-3.5) attacks the pellet. Enteric coating resists acid — NADH stays 100% protected. No degradation.
At pH 6.0+ in the small intestine, the enteric coating dissolves. The sustained-release membrane begins 24-hour controlled diffusion.
Soluble wall matrix dissolves fully. NADH absorbed through intestinal villi into the bloodstream. NAD+ levels elevated within 15 minutes.
NADH enters mitochondria, donates electrons to the electron transport chain, drives ATP synthesis. 24h sustained NAD+ elevation.
Diverse applications across pharmaceutical, nutraceutical, and functional food industries.
Boosts cellular NAD+ levels, activates Sirtuins longevity proteins, and improves mitochondrial function. NADH levels decline 40% from age 20 to 60.
Directly participates in ATP synthesis via mitochondrial electron transport chain. Improves chronic fatigue syndrome and physical endurance.
NASA-confirmed effectiveness in improving cognitive function. Supports memory, attention, alertness, and neuroprotection.
Enhances athletic performance and recovery. Animal studies show 30% improvement in exercise endurance and 25% increase in muscle strength.
The body's most powerful electron donor. Activates SOD and CAT antioxidant enzyme systems to scavenge free radicals.
NADH is the coenzyme of alcohol dehydrogenase. Accelerates alcohol metabolism and provides liver protection.
Contact our technical team today to discuss your formulation requirements, request samples, or get a customized quotation.
